Company intelligence / Profile preview

BioLucent

Aliso Viejo, California, USA

Ownership: Private
Employees: ~30
Development stage: Other

Overview

BioLucent was a medical technology company focused on improving the patient experience in women's healthcare, specifically within breast cancer screening and treatment. The company's primary commercial success was the MammoPad, a radiolucent breast cushion that reduces the discomfort of mammography, thereby encouraging better screening compliance. BioLucent also developed the SAVI brachytherapy applicator for breast cancer treatment, which was later spun off into Cianna Medical. In September 2007, Hologic acquired BioLucent for $70 million to integrate the MammoPad into its breast health portfolio.

Therapeutic areas: Oncology
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on BioLucent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLucent.

Explore the full profile